This brochure outlines PATH's work in China, where we collaborate with government agencies, nongovernmental organizations, research institutes, and manufacturers to improve health and save lives. With technical assistance from PATH, China is becoming a leading supplier of lifesaving health technologies and products for use in low-resource settings. Programmatic areas include tuberculosis, vaccines and immunization, neglected tropical diseases, and reproductive health.

Publication date: February 2017

Region: Asia

Part of series: Country brochures

This brochure outlines PATH’s work to improve health in Uganda. Key areas of focus include cervical cancer prevention, detection, and treatment; vaccines and immunization, including supply chain improvements; advocacy to improve the quality and availability of health care services; and introduction of Sayana® Press, a popular new form of injectable contraceptive.

Publication date: January 2017

Region: Africa

Part of series: Country brochures

RHO Cervical Cancer is an online resource for health program managers and decision-makers seeking to prevent cervical cancer in low-resource settings. The site contains information about human papillomavirus and cervical cancer, cervical cancer screening and treatment, and the role of vaccination in cervical cancer prevention.

Publication date: 2017

Region: Global

Part of series: Websites

PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers a wide variety of high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. It is geared for health professionals in the developing and industrialized worlds, as well as for journalists, policymakers, community leaders, parents, and others interested in vaccine-related resources. The resources found on the VRL are collected from a variety of sources, including news media, scientific journals, and leaders in public health.

Publication date: 2017

Region: Global

Part of series: Websites

PATH conducted a landscape analysis of cervical cancer screening in Kenya, Tanzania, and Uganda to clarify opportunities for HPV testing as a primary cervical cancer screening method in these countries. We conducted stakeholder interviews and meetings in each country to discuss the decision-making process for test introduction, potential advantages of HPV testing, and anticipated barriers to introduction and ways to overcome them.

Publication date: December 2016

Region: Africa

To aid decision-makers interested in HPV vaccine introduction or scale-up, the London School of Hygiene & Tropical Medicine and PATH completed the first comprehensive review of HPV vaccine delivery experiences across 46 low- and middle-income countries. Highlights include key findings and lessons from HPV vaccination experience across five themes: preparation, communications, delivery, achievements, and sustainability. Also addressed are the value of demonstration projects and potential HPV vaccination pitfalls. This suite of resources synthesizes findings from this review.

To access these documents and videos in English, French, and Spanish please visit: http://www.rho.org/HPVlessons.

Publication date: September 2016

Region: Global

Very few women in low-resource settings are able to receive treatment for cervical precancer when they need it. Through the Cryotherapy Market Dynamics Project, PATH undertook an analysis of supply-and-demand factors to determine whether there are market interventions that could ameliorate the current low levels of treatment coverage.

Publication date: August 2015

Region: Global

For over two decades, PATH has championed technical, systems, and policy innovations to reduce cervical cancer deaths among the world’s poorest women. This brief describes our contributions to advances in cervical cancer prevention and outlines our continued work to expand access to evidence-based primary prevention, screening, and preventive treatment programs.

Publication date: June 2015

Region: Global

HPVflash is an email news bulletin that disseminates useful cervical cancer prevention information, including updates on vaccines against the human papillomavirus, to interested persons worldwide. HPVflash emails are emailed only a few times a year.

Publication date: 2015

Region: Global

Part of series: E-newsletters

This fact sheet outlines PATH's role in providing technical assistance to countries for the planning, implementation, and evaluation of human papillomavirus (HPV) vaccination programs. The PATH HPV vaccine team’s activities are channeled through four primary work streams: Gavi, the Vaccine Alliance application support; program planning and implementation; evaluation; and cervical cancer prevention and control strategies.

Publication date: December 2014

Region: Global

Cervical Cancer Action is a global partnership chaired by PATH and aimed at reducing cervical cancer in high-burden, low-income countries. Seven years after its founding and eight years after human papillomavirus vaccines first became available, Cervical Cancer Action offers this snapshot of its accomplishments to date and its vision of the work ahead.

Publication date: April 2014

Region: Global

This fact sheet outlines PATH's work on vaccines and immunization. Topic areas include developing affordable vaccines, designing innovative vaccine technologies, and expanding uptake of existing vaccines. These efforts reduce the burden of malaria, meningitis, diarrheal disease, Japanese encephalitis, pneumococcal disease, influenza, rotavirus, polio, respiratory syncytial virus (RSV), and other infectious diseases in developing countries.

Publication date: December 2013

Region: Global

Part of series: Areas of focus fact sheets

This paper documents the accomplishments of the PATH-led Alliance for Cervical Cancer Prevention (ACCP). The report also presents the state of knowledge about alternative screening strategies prior to the establishment of the partnership, as well as contributions of researchers not affiliated with ACCP.

Author: Gaffikin L, Wittet S, and Sherris J

Publication date: August 2013

Region: Global

Supported by a seed grant from the World Bank, PATH began to focus on cervical cancer in 1991. Since then, our portfolio has expanded tremendously, thanks in large part to grants from the Bill & Melinda Gates Foundation. In this report, we describe our key cervical cancer prevention initiatives.

Publication date: April 2013

Region: Global

The journal Vaccine published a special supplement on the Decade of Vaccines Global Vaccine Action Plan (GVAP) that features articles by PATH contributors and others on the GVAP strategic objectives and the opportunities and challenges associated with its implementation. The 27 articles cover a range of related topics, including vaccine development, financing, access, delivery, and health impact. More than 100 authors contributed to the supplement representing a variety of international and developing-country stakeholders, from civil society and academia to vaccine manufacturers and policymakers.

Author: Glassman A, Zoloa JI, Duran D, et al

Publication date: April 2013

Region: Global

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Vietnam by PATH, the Vietnam National Institute of Hygiene and Epidemiology, and the Vietnam National Center for Health Education and Communication through the HPV Vaccines: Evidence for Impact project. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in Southeast Asia, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: November 2012

Region: Asia

Part of series: HPV vaccination project lessons learned reports

These documents provide stability data as of November 2012 on commonly used, licensed vaccines and stability data as of May 2012 from available data on novel, investigational vaccine formulations. Data are sorted by vaccine in a table format.

Publication date: November 2012

Region: Global

The Global Vaccine Action Plan (GVAP)—endorsed by the 194 Member States of the World Health Assembly in May 2012—is a roadmap to prevent millions of deaths by 2020 through more equitable access to vaccines for people in all communities. The GVAP aims to strengthen routine immunization, introduce new and improved vaccines, and advance research and development for the next generation of vaccines and technologies.

Author: Decade of Vaccines Collaboration

Publication date: May 2012

Region: Global

The Cold Chain Equipment Manager (CCEM) is a Microsoft Access–based software tool. It is accompanied by a user manual, data collection questionnaires, a surveyor’s guide to these questionnaires, and an equipment identification guide. CCEM also comes with practice files, providing new users with practice data to demonstrate how CCEM will analyze cold chain equipment data and facilitate multiyear equipment planning. CCEM version 2.1 is available for download (see below) or, to request a copy on CD, email CCEMinfo@path.org.

Publication date: January 2012

Region: Global

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website summarizing lessons learned to guide cervical cancer prevention program planning in low-resource settings. It demonstrates that formative research is a necessary component of overall planning, discusses formative research issues specific to cervical cancer, and explains how research results may be used for strategic planning within the cervical cancer context.

Publication date: 2012

Region: Global